U.S. market Open. Closes in 5 hours 26 minutes

GSK | GSK plc Stock Overview

(Stock Exchange: NYSE)
Day's Range 37.89 - 38.84
52 Week Range 31.72 - 45.93
Beta 0.58
Implied Volatility 23.87%
IV Rank 65.98%
Day's Volume 5,124,077
Average Volume 4,886,169
Shares Outstanding 2,033,897,847
Market Cap 78,793,202,593
Sector Healthcare
Industry Drug Manufacturers - General
IPO Date 1980-03-28
Valuation
Profitability
Growth
Health
P/E Ratio 24.21
Forward P/E Ratio 12.26
EPS 1.60
1YR Price Target 51.00
Dividend Yield 4.14%
Dividend Per Share 1.60
Dividend ExDate 2022-08-18
Dividend PayDate 2022-10-06
Employees 70,212
Country UK
Website GSK
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines.
GSK's peers: AMRN, AZN, BIIB, GRFS, NVS, RHHBY, BMY, AMGN, MRK, ABBV, GILD, JNJ, SNY, SCLX
*Chart delayed
Analyzing fundamentals for GSK we got that it has weak fundamentals where Valuation is considered to be slightly undervalued, Profitability is very poor, Growth is very bad and Health is weak. For more detailed analysis please see GSK Fundamentals page.

Watching at GSK technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, but short-term trend is bearish. More technicals details can be found on GSK Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙